Key Takeaways
- • Andreessen Horowitz announced on Oct. 22 that its crypto investment arm, a16z Crypto, is being renamed a16z Frontier, broadening its mandate to emerging technology while keeping crypto in scope.
- • The expanded mandate covers AI products and autonomous machines, biology and medicine, and networks linking people with AI agents, with investments in technologies that may take years to develop.
- • Managing partner Chris Dixon said the change "is an expansion" and that the firm will continue to invest in crypto and advocate for sensible crypto regulation.
- • The firm did not disclose how much capital will go to crypto or how the fund will allocate across its broader mandate.
Summary
Andreessen Horowitz (a16z) is widening the investment scope of its crypto arm by renaming a16z Crypto as a16z Frontier, according to a TokenPost report. The firm announced the change on Oct. 22, 2026, stating that the fund will invest in technologies and markets that may take years to develop. The name change confirms a move TokenPost had previously reported as under consideration.
The expanded remit covers AI products and autonomous machines, work in biology and medicine, and networks linking people with AI agents. Managing partner Chris Dixon will lead the fund alongside a16z founders Marc Andreessen and Ben Horowitz, and general partners Eddy Lazzarin and Guy Wuollet. Dixon stressed that the change does not end crypto investing: "This is an expansion: we will continue to invest in crypto and related ventures and advocate for sensible crypto regulation."
Dixon attributed the shift to the growing overlap between blockchain and traditional finance. Blockchain use across Wall Street and fintech has, in his view, blurred the lines between crypto companies and other technology businesses. "Blockchains will play a significant role in this transformation," he said. The firm argues that crypto can give new networks native economic capabilities and enable machine-to-machine transactions.
The announcement did not specify how much capital will be directed toward crypto or how the fund will divide investments across its broader mandate, leaving allocation questions unresolved for allocators tracking the vehicle.
The expanded remit covers AI products and autonomous machines, work in biology and medicine, and networks linking people with AI agents. Managing partner Chris Dixon will lead the fund alongside a16z founders Marc Andreessen and Ben Horowitz, and general partners Eddy Lazzarin and Guy Wuollet. Dixon stressed that the change does not end crypto investing: "This is an expansion: we will continue to invest in crypto and related ventures and advocate for sensible crypto regulation."
Dixon attributed the shift to the growing overlap between blockchain and traditional finance. Blockchain use across Wall Street and fintech has, in his view, blurred the lines between crypto companies and other technology businesses. "Blockchains will play a significant role in this transformation," he said. The firm argues that crypto can give new networks native economic capabilities and enable machine-to-machine transactions.
The announcement did not specify how much capital will be directed toward crypto or how the fund will divide investments across its broader mandate, leaving allocation questions unresolved for allocators tracking the vehicle.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.